17 Jul 2018 | 2:57 PM
Research Report

Equity Research Report: Religare Morning Digest

We believe the recent upmove in Bank Nifty will extend further in the coming sessions and it would further fuel the prevailing recovery in the benchmark Nifty index.
10 Apr 2015 | 07:00 AM

Global rating agency, Moody’s Investors Service upgraded India’s growth outlook to positive from stable and retained the sovereign rating at Baa3, observing that the actions of policymakers would strengthen the country's economic growth.


Aurobindo Pharma received final approvals from the US Food & Drug Administration to manufacture and market Atracurium Besylate Injection.


Bajaj Corp net profit rose 42.05% to Rs 54.42 crore on 27.99% rise in total income from operations to Rs 236.17 crore in Q4 March 2015 over Q4 March 2014.